Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 27 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7999113

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  2. US 7998987

    Inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  3. US 7994166

    Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain

    Vertex Pharmaceuticals Incorporated · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  4. US 7994174

    Pyridyl sulfonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  5. US 7989481

    Indane derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  6. US 7989456

    Pyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  7. US 7989498

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  8. US 7985769

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  9. US 7985762

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  10. US 7982037

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  11. US 7977322

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  12. US 7973162

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  13. US 7973038

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  14. US 7973169

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  15. US 7972813

    Tetrodotoxin-resistant sodium channel alpha subunit

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  16. US 7968545

    Compositions useful as inhibitors of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  17. US 7968716

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  18. US 7964624

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  19. US 7960415

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  20. US 7960398

    Regulation of TNF-alpha

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  21. US 7956052

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted

  22. US 7951809

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted

  23. US 7951820

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted

  24. US 7943593

    Compositions comprising inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2011 · Expires May 12, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.